{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:26:17Z","timestamp":1792589177445,"version":"4.5.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008390","name":"Danish Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.molmet.2020.101109","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T23:04:49Z","timestamp":1604703889000},"page":"101109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases"],"prefix":"10.1016","volume":"46","author":[{"given":"Nina","family":"Sonne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-8740","authenticated-orcid":false,"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2020.101109_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.molmet.2020.101109_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25","volume":"175","author":"Hay","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib3","series-title":"RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors","first-page":"115","author":"Pioszak","year":"2020"},{"key":"10.1016\/j.molmet.2020.101109_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.molmet.2020.101109_bib5","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.molmet.2020.101109_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2174\/1389203720666190328111833","article-title":"Human amylin: from pathology to physiology and pharmacology","volume":"20","author":"Ling","year":"2019","journal-title":"Current Protein & Peptide Science"},{"key":"10.1016\/j.molmet.2020.101109_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2020.101109_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-017-1404-4","article-title":"Role of calcitonin gene-related peptide in energy metabolism","volume":"58","author":"Lima","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.molmet.2020.101109_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acsptsci.9b00089","article-title":"Distinct patterns of internalization of different calcitonin gene-related peptide receptors","volume":"3","author":"Gingell","year":"2020","journal-title":"ACS Pharmacology Translational Science"},{"key":"10.1016\/j.molmet.2020.101109_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tips.2018.11.005","article-title":"New insights into the regulation of CGRP-family receptors","volume":"40","author":"Gingell","year":"2019","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.molmet.2020.101109_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00503-X","article-title":"Evidence for a physiological role of central calcitonin gene-related peptide (CGRP) receptors in the control of food intake in rats","volume":"230","author":"Lutz","year":"1997","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.molmet.2020.101109_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/endo-70-5-638","article-title":"Evidence for calcitonin\u2014a new hormone from the parathyroid that lowers blood calcium","volume":"70","author":"Copp","year":"1962","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(63)90224-1","article-title":"Further evidence for calcitonin a rapid-acting hormone which lowers plasma-calcium","volume":"282","author":"Ashwini Kumar","year":"1963","journal-title":"Lancet"},{"issue":"80","key":"10.1016\/j.molmet.2020.101109_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.146.3642.412","article-title":"Hypocalcemic hypophosphatemic principle of the thyroid gland","volume":"146","author":"Hirsch","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.molmet.2020.101109_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10408369009105900","article-title":"The calcitonin gene peptides: biology and clinical relevance","volume":"28","author":"Zaidi","year":"1990","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"issue":"80","key":"10.1016\/j.molmet.2020.101109_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1126\/science.158.3803.924","article-title":"Calcitonin from ultimobranchial glands of Dogfish and chickens","volume":"158","author":"Copp","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.molmet.2020.101109_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF01927568","article-title":"Synthesis of Eel-Calcitonin and [Asu1,7]-Eel-Calcitonin: contribution of the disulfide bond to the hormonal activity","volume":"32","author":"Morikawa","year":"1976","journal-title":"Experientia"},{"key":"10.1016\/j.molmet.2020.101109_bib18","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.1152\/ajpendo.00419.2016","article-title":"Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog","volume":"313","author":"Gydesen","year":"2017","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2012.01979.x","article-title":"Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats","volume":"167","author":"Feigh","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2020.101109_bib21","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.1993.1881","article-title":"Cloning and characterization of cDNA encoding a precursor for human adrenomedullin","volume":"194","author":"Kitamura","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2020.101109_bib22","doi-asserted-by":"crossref","first-page":"170347","DOI":"10.1016\/j.peptides.2020.170347","article-title":"Adrenomedullin \u2013 current perspective on a peptide hormone with significant therapeutic potential","volume":"131","author":"Fischer","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib23","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M305332200","article-title":"Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes","volume":"279","author":"Roh","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2020.101109_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(03)01368-1","article-title":"Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator","volume":"556","author":"Takei","year":"2004","journal-title":"FEBS Letters"},{"key":"10.1016\/j.molmet.2020.101109_bib25","first-page":"S247","article-title":"Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems","volume":"153","author":"Bell","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib26","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1074\/jbc.M207970200","article-title":"Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family","volume":"278","author":"Katafuchi","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2020.101109_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ejhf.1366","article-title":"Adrenomedullin in heart failure: pathophysiology and therapeutic application","volume":"21","author":"Voors","year":"2019","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.molmet.2020.101109_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1476-5381.2011.01530.x","article-title":"The pharmacology of adrenomedullin 2\/intermedin","volume":"166","author":"Hong","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"80","key":"10.1016\/j.molmet.2020.101109_bib29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.1658940","article-title":"Expression cloning of an adenylate cyclase-coupled calcitonin receptor","volume":"254","author":"Lin","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.molmet.2020.101109_bib30","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI116046","article-title":"Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line","volume":"90","author":"Gorn","year":"1992","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2020.101109_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2613.2000.00176.x","article-title":"Calcitonin and calcitonin receptors: bone and beyond","volume":"81","author":"Pondel","year":"2000","journal-title":"International Journal of Experimental Pathology"},{"key":"10.1016\/j.molmet.2020.101109_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1995.1047","article-title":"A\u00a0human orphan calcitonin receptor-like structure","volume":"206","author":"Fluhmann","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2020.101109_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2020.101109_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0333102418765787","article-title":"Molecular studies of CGRP and the CGRP family of peptides in the central nervous system","volume":"39","author":"Hendrikse","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.molmet.2020.101109_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10606820213681","article-title":"Molecular pharmacology of the calcitonin receptor","volume":"8","author":"Purdue","year":"2002","journal-title":"Receptors and Channels"},{"key":"10.1016\/j.molmet.2020.101109_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092042","article-title":"Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias","volume":"9","author":"Andreassen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2020.101109_bib38","doi-asserted-by":"crossref","first-page":"21925","DOI":"10.1074\/jbc.M116.751362","article-title":"Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors","volume":"291","author":"Weston","year":"2016","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2020.101109_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2011.01717.x","article-title":"Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes","volume":"166","author":"Bailey","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tips.2010.06.006","article-title":"Regulation of signal transduction by calcitonin gene-related peptide receptors","volume":"31","author":"Walker","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.molmet.2020.101109_bib41","doi-asserted-by":"crossref","first-page":"170366","DOI":"10.1016\/j.peptides.2020.170366","article-title":"Amylin brain circuitry","volume":"132","author":"Boccia","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib42","doi-asserted-by":"crossref","first-page":"E821","DOI":"10.1152\/ajpendo.00514.2015","article-title":"KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight","volume":"310","author":"Gydesen","year":"2016","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2016.09.021","article-title":"Ligand-dependent modulation of G protein conformation alters drug efficacy","volume":"167","author":"Furness","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2020.101109_bib44","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00121.2014","article-title":"A\u00a0novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats","volume":"307","author":"Andreassen","year":"2014","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib45","first-page":"2016","article-title":"Optimization of tolerability and efficacy of dual amylin and calcitonin receptor agonist, KBP-089, through dose escalation and combination with a GLP-1 analogue","author":"Gydesen","year":"2017","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.119.257576","article-title":"The dual amylin and calcitonin receptor agonist KBP-088 induces weight loss and improves insulin sensitivity superior to chronic amylin therapy","volume":"370","author":"Larsen","year":"2019","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.molmet.2020.101109_bib48","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obesity Metabolic"},{"key":"10.1016\/j.molmet.2020.101109_bib49","first-page":"2015","article-title":"KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight","author":"Gydesen","year":"2016","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib50","author":"Hay"},{"key":"10.1016\/j.molmet.2020.101109_bib53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1152\/physrev.00066.2017","article-title":"The activity of peptides of the calcitonin family in bone","volume":"99","author":"Naot","year":"2019","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.molmet.2020.101109_bib54","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/endo.140.6.6930","article-title":"An amylin receptor is revealed following Co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3","volume":"140","author":"Muff","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-pharmtox-010715-103120","article-title":"Receptor activity-modifying proteins (RAMPs): new insights and roles","volume":"56","author":"Hay","year":"2016","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.molmet.2020.101109_bib56","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.1998.275.5.R1537","article-title":"Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats","volume":"275","author":"Arnelo","year":"1998","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450053174596","article-title":"Pancreatic amylin as a centrally acting satiating hormone","volume":"6","author":"Lutz","year":"2005","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.molmet.2020.101109_bib58","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2009-2133","article-title":"Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?","volume":"95","author":"Asmar","year":"2010","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib59","series-title":"Proceedings annual meeting of the society for the study of ingestive behavior","article-title":"Amylin reduces food intake in rats at doses that cause only slightly supraphysiological plasma amylin levels","author":"Lutz","year":"1996"},{"key":"10.1016\/j.molmet.2020.101109_bib60","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2007-978923","article-title":"Nephrectomy decreases amylin and pramlintide clearance in rats","volume":"30","author":"Vine","year":"1998","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.molmet.2020.101109_bib61","first-page":"131","article-title":"Increased levels of plasma amylin in advanced renal failure","volume":"37","author":"Watschinger","year":"1992","journal-title":"Clinical Nephrology"},{"key":"10.1016\/j.molmet.2020.101109_bib62","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/0024-3205(93)90480-Q","article-title":"Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat","volume":"52","author":"Young","year":"1993","journal-title":"Life Sciences"},{"key":"10.1016\/j.molmet.2020.101109_bib63","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2015.10.012","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib64","doi-asserted-by":"crossref","DOI":"10.1677\/jme.0.003R001","article-title":"Expression of the rat amylin (IAPP\/DAP) gene","volume":"3","author":"Ferrier","year":"1989","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1677\/jme.0.0090157","article-title":"Extra-pancreatic expression of the rat islet amyloid polypeptide (amylin) gene","volume":"9","author":"Nicholl","year":"1992","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-291X(05)81416-0","article-title":"Identification and characterization of islet amyloid polypeptide in mammalian gastrointestinal tract","volume":"181","author":"Miyazato","year":"1991","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2020.101109_bib67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)","volume":"250","author":"Gebre-Medhin","year":"1998","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2020.101109_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/00365521.2011.638392","article-title":"Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP","volume":"47","author":"Olsson","year":"2012","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.molmet.2020.101109_bib69","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","article-title":"Inhibition of central amylin signaling increases food intake and body adiposity in rats","volume":"142","author":"Rushing","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.physbeh.2004.01.006","article-title":"Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats","volume":"81","author":"Mollet","year":"2004","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.molmet.2020.101109_bib71","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1152\/ajpregu.00213.2004","article-title":"Amylin receptor blockade stimulates food intake in rats","volume":"287","author":"Reidelberger","year":"2004","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib72","doi-asserted-by":"crossref","first-page":"R355","DOI":"10.1152\/ajpregu.00462.2015","article-title":"Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity","volume":"310","author":"Dunn-Meynell","year":"2016","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib73","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0026-0495(95)90079-9","article-title":"Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity","volume":"44","author":"Young","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib74","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2020.101109_bib75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187","volume":"137","author":"Gedulin","year":"2006","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib77","series-title":"Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas","author":"Silvestre","year":"2001"},{"key":"10.1016\/j.molmet.2020.101109_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112958","article-title":"Distributed amylin receptor signaling and its influence on motivated behavior","volume":"222","author":"Kern","year":"2020","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.molmet.2020.101109_bib79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00063030-200822030-00001","article-title":"Calcitonin??? A drug of the past or for the future?","volume":"22","author":"Karsdal","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmet.2020.101109_bib80","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bone.2010.09.013","article-title":"The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption","volume":"48","author":"Turner","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2020.101109_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180547","article-title":"Differential effects of Calca-derived peptides in male mice with diet-induced obesity","volume":"12","author":"Bartelt","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2020.101109_bib82","first-page":"217","article-title":"Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor","volume":"42","author":"Armour","year":"2000","journal-title":"Journal of Pharmacology and Toxicology"},{"key":"10.1016\/j.molmet.2020.101109_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35369-5","article-title":"Endogenous calcitonin regulates lipid and glucose metabolism in diet-induced obesity mice","volume":"8","author":"Nakamura","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2020.101109_bib84","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/jpet.119.263392","article-title":"The calcitonin receptor plays a major role in glucose regulation as a function of dual amylin and calcitonin receptor agonist therapy","volume":"374","author":"Larsen","year":"2020","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bph.13723","article-title":"A\u00a0novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference","volume":"174","author":"Gydesen","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib86","first-page":"241281","article-title":"The dual amylin- and calcitonin receptor agonist KBP-042 works as adjunct to metformin on fasting hyperglycaemia and HbA1c in a rat model of type 2 diabetes","author":"Hjuler","year":"2017","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1467-789X.2009.00669.x","article-title":"Regulation of lipid metabolism by energy availability: a role for the central nervous system","volume":"11","author":"Nogueiras","year":"2010","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.molmet.2020.101109_bib88","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/308653a0","article-title":"Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells","volume":"308","author":"Mason","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2020.101109_bib89","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1523\/JNEUROSCI.04-12-03101.1984","article-title":"Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species","volume":"4","author":"Gibson","year":"1984","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.molmet.2020.101109_bib90","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.molmet.2020.101109_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0163-7258(92)90036-Y","article-title":"Calcitonin gene-related peptide: multiple actions, multiple receptors","volume":"56","author":"Poyner","year":"1992","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib92","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1210\/en.2010-0284","article-title":"Mice lacking the neuropeptide \u03b1-calcitonin gene-related peptide are protected against diet-induced obesity","volume":"151","author":"Walker","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib93","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/en.2016-1510","article-title":"Endogenous calcitonin gene-related peptide regulates lipid metabolism and energy homeostasis in male mice","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib94","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.cell.2014.03.051","article-title":"TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling","volume":"157","author":"Riera","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2020.101109_bib95","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","article-title":"Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus","volume":"183","author":"Betsholtz","year":"1989","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.molmet.2020.101109_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Development Research"},{"key":"10.1016\/j.molmet.2020.101109_bib97","doi-asserted-by":"crossref","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","article-title":"Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight","volume":"293","author":"Mack","year":"2007","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib98","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postremaanucleus of the solitary tract (APaNTS) lesioned rats","volume":"25","author":"Lutz","year":"2001","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.molmet.2020.101109_bib99","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.molmet.2020.101109_bib100","first-page":"1654","article-title":"Chronic infusion of islet amyloid polypeptide causes anorexia in rats","volume":"271","author":"Arnelo","year":"1996","journal-title":"American Journal for Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib101","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/npp.2013.66","article-title":"Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake","volume":"38","author":"Mietlicki-baase","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib102","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.90327.2008","article-title":"Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys","volume":"295","author":"Bello","year":"2008","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib103","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the \u03b2-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0196-9781(02)00022-0","article-title":"Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences","volume":"23","author":"Rushing","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib105","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0196-9781(92)90057-A","article-title":"Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin","volume":"13","author":"Chance","year":"1992","journal-title":"Peptides"},{"issue":"80","key":"10.1016\/j.molmet.2020.101109_bib106","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.493987","article-title":"Calcitonin: inhibitory effect on eating in rats","volume":"206","author":"Freed","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.molmet.2020.101109_bib107","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/oby.21563","article-title":"The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity","volume":"24","author":"Hjuler","year":"2016","journal-title":"Obesity (Silver Spring)."},{"key":"10.1016\/j.molmet.2020.101109_bib108","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.263400","article-title":"Dose frequency optimization of the dual amylin and calcitonin receptor agonist KBP-088: long-lasting improvement of food preference and body weight loss","volume":"373","author":"Larsen","year":"2020","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2015.05.051","article-title":"KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration","volume":"762","author":"Hjuler","year":"2015","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000084488","article-title":"Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis","volume":"5","author":"Issakson","year":"2005","journal-title":"Pancreatology"},{"key":"10.1016\/j.molmet.2020.101109_bib111","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.physbeh.2007.02.012","article-title":"The acute effect of amylin and salmon calcitonin on energy expenditure","volume":"91","author":"Wielinga","year":"2007","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.molmet.2020.101109_bib112","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.physbeh.2010.04.012","article-title":"Central amylin acts as an adiposity signal to control body weight and energy expenditure","volume":"101","author":"Wielinga","year":"2010","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.molmet.2020.101109_bib113","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ijo.2010.262","article-title":"Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats","volume":"35","author":"Seth","year":"2011","journal-title":"International Journal of Obesity(Lond)"},{"key":"10.1016\/j.molmet.2020.101109_bib114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-0115(95)00009-Z","article-title":"In\u00a0vivo central actions of rat amylin","volume":"56","author":"Bouali","year":"1995","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib115","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.2337\/db16-0240","article-title":"Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation","volume":"65","author":"F\u00e6rch","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2020.101109_bib116","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1463-1326.2011.01425.x","article-title":"A\u00a0novel oral form of salmon calcitonin improves homeostasis and reduces body weight in diet-induced obese rats","volume":"13","author":"Feigh","year":"2011","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2017.05.024","article-title":"Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior","volume":"123","author":"Mietlicki-Baase","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib118","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/db17-1347","article-title":"Amylin selectively signals onto POMC neurons in the arcuate nucleus of the hypothalamus","volume":"67","author":"Lutz","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2020.101109_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2017.03.023","article-title":"The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc)","volume":"176","author":"Whiting","year":"2017","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.molmet.2020.101109_bib120","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1111\/ejn.12672","article-title":"The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping","volume":"40","author":"Braegger","year":"2014","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.molmet.2020.101109_bib121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2008.03.010","article-title":"Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy","volume":"148","author":"Wickbom","year":"2008","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib122","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0196-9781(94)00203-I","article-title":"Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin","volume":"16","author":"Lutz","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib123","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mce.2012.12.008","article-title":"Amylin stimulates fatty acid esterification in 3T3-L1 adipocytes","volume":"366","author":"Miegueu","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000084488","article-title":"Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis","volume":"5","author":"Isaksson","year":"2005","journal-title":"Pancreatology"},{"key":"10.1016\/j.molmet.2020.101109_bib125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in\u00a0vitro and ex\u00a0vivo studies in humans","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2020.101109_bib126","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle","volume":"85","author":"Cooper","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2020.101109_bib127","first-page":"13","article-title":"No measurable effect of amylin on lipolysis in either white or brown isolated adipocytes from rats","volume":"6","author":"Lupien","year":"1993","journal-title":"Diabetes, Nutrition Metabolic"},{"key":"10.1016\/j.molmet.2020.101109_bib128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0014-5793(95)00449-J","article-title":"Amylin and epinephrine have no direct effect on glucose transport in isolated rat soleus muscle","volume":"365","author":"Pittner","year":"1995","journal-title":"FEBS Letters"},{"key":"10.1016\/j.molmet.2020.101109_bib129","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.1990.259.3.E457","article-title":"Effects of amylin in glucose metabolism and glycogenolysis in\u00a0vivo and in\u00a0vitro","volume":"259","author":"Young","year":"1990","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj2690019","article-title":"The effects of amylin on carbohydrate metabolism in skeletal muscle in\u00a0vitro and in\u00a0vivo","volume":"269","author":"Leighton","year":"1990","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.molmet.2020.101109_bib131","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.1993.264.4.E606","article-title":"Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor","volume":"264","author":"Kreutter","year":"1993","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib132","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","article-title":"Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in\u00a0vitro","volume":"335","author":"Leighton","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2020.101109_bib133","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2006-2003","article-title":"Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study","volume":"92","author":"Aronne","year":"2007","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib134","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/15209150252924094","article-title":"Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes","volume":"4","author":"Ratner","year":"2002","journal-title":"Diabetes Technology & Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","article-title":"A\u00a0randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes","volume":"25","author":"Whitehouse","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2020.101109_bib136","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03349315","article-title":"Effects of salmon calcitonin on blood glucose and insulin levels under basal conditions and after intravenous glucose load","volume":"2","author":"Petralito","year":"1979","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.molmet.2020.101109_bib137","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jcem-53-2-318","article-title":"Calcitonin, A diabetogenic hormone?","volume":"53","author":"Passariello","year":"1981","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib138","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jcem-51-2-354","article-title":"Effect of acute and chronic administration of calcitonin on serum glucose in patients with paget's disease of bone","volume":"51","author":"Gattereau","year":"1980","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib139","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-5793(91)81113-M","article-title":"Amylin injection causes elevated plasma lactate and glucose in the rat","volume":"291","author":"Young","year":"1991","journal-title":"FEBS Letters"},{"key":"10.1016\/j.molmet.2020.101109_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176039","article-title":"There and back again: leptin actions in white adipose tissue","volume":"21","author":"Mart\u00ednez-S\u00e1nchez","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.molmet.2020.101109_bib141","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2020.101109_bib142","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S1092852913000667","article-title":"Metabolic syndrome and major depression","volume":"19","author":"Marazziti","year":"2014","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.molmet.2020.101109_bib143","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00198.2011","article-title":"Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice","volume":"302","author":"Kusakabe","year":"2012","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib144","doi-asserted-by":"crossref","first-page":"R856","DOI":"10.1152\/ajpregu.00179.2018","article-title":"Rodent models of leptin receptor deficiency are less sensitive to amylin","volume":"315","author":"Duffy","year":"2018","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2016.11.004","article-title":"Amylin and leptin: Co-regulators of energy homeostasis and neuronal development","volume":"28","author":"Levin","year":"2017","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib146","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1476-5381.2011.01537.x","article-title":"GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities","volume":"166","author":"Roth","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib147","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2337\/db14-1910","article-title":"Brain IL-6 - where amylin and GLP-1 antiobesity signaling congregate","volume":"64","author":"Jansson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2020.101109_bib148","doi-asserted-by":"crossref","first-page":"R945","DOI":"10.1152\/ajpregu.00275.2010","article-title":"Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates","volume":"299","author":"Bello","year":"2010","journal-title":"American Journal of Physiology Integrative Comparative Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib149","author":"No"},{"key":"10.1016\/j.molmet.2020.101109_bib150","series-title":"Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combination trial with AM833 and semaglutide in obesity","author":"Nordisk","year":"2020"},{"key":"10.1016\/j.molmet.2020.101109_bib151","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/dom.13009","article-title":"Insulin-associated weight gain in obese type 2 diabetes mellitus patients: what can be done?","volume":"19","author":"Brown","year":"2017","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib152","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/oby.2009.478","article-title":"Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial","volume":"18","author":"Aronne","year":"2010","journal-title":"Obesity (Silver Spring)."},{"key":"10.1016\/j.molmet.2020.101109_bib153","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)."},{"key":"10.1016\/j.molmet.2020.101109_bib154","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/dmrr.419","article-title":"Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study","volume":"20","author":"Maggs","year":"2004","journal-title":"Diabetes Metabolism Research Review"},{"key":"10.1016\/j.molmet.2020.101109_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.26.1.1","article-title":"Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps","volume":"26","author":"Levetan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2020.101109_bib156","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diacare.18.8.1179","article-title":"Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue","volume":"18","author":"Kolterman","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2020.101109_bib157","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001250050949","article-title":"The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM","volume":"41","author":"Kong","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2020.101109_bib158","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.molmet.2020.101109_bib159","doi-asserted-by":"crossref","DOI":"10.1089\/15209150260007390","article-title":"Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second b-cell hormone","volume":"4","author":"Edelman","year":"2002","journal-title":"Diabetes Technology & Therapeutics"},{"key":"10.1016\/j.molmet.2020.101109_bib160","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00400639","article-title":"Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM","volume":"38","author":"Dinneen","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2020.101109_bib161","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"34","author":"Fineman","year":"2002","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.molmet.2020.101109_bib162","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0026-0495(99)90232-9","article-title":"The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus","volume":"48","author":"Nyholm","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib163","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2020.101109_bib164","first-page":"784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes","volume":"25","author":"Hollander","year":"2003","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.molmet.2020.101109_bib165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/oby.2004.76","article-title":"Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients","volume":"12","author":"Hollander","year":"2004","journal-title":"Obesity Research"},{"key":"10.1016\/j.molmet.2020.101109_bib166","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2337\/dc06-0042","article-title":"A\u00a0double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes","volume":"29","author":"Edelman","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2020.101109_bib167","series-title":"Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes","author":"Wysham","year":"2007"},{"key":"10.1016\/j.molmet.2020.101109_bib168","series-title":"Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials","author":"Herrmann","year":"2016"},{"key":"10.1016\/j.molmet.2020.101109_bib169","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"MacMahon","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2020.101109_bib170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2020.101109_bib171","article-title":"Effects of a selective long-acting amylin receptor agonist on alcohol consumption, food intake and body weight in male and female rats","author":"Kalafateli","year":"2020","journal-title":"Addiction Biology"},{"key":"10.1016\/j.molmet.2020.101109_bib172","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1038\/s41598-019-44591-8","article-title":"Combined Amylin\/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss","volume":"9","author":"Liberini","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2020.101109_bib173","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.peptides.2019.04.004","article-title":"BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats","volume":"114","author":"Nascimento","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib175","first-page":"1993","article-title":"Deconstruction of the role of the amylin and calcitonin receptors in the regulation of body weight and glucose tolerance","author":"Larsen","year":"2019","journal-title":"American Diabetes Association"},{"key":"10.1016\/j.molmet.2020.101109_bib176","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0196-9781(84)90107-4","article-title":"Effects of calcitonin gene-related peptide on food intake","volume":"5","author":"Krahn","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib177","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0196-9781(98)00114-4","article-title":"Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2020.101109_bib178","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1210\/en.2007-0583","article-title":"Evidence that \u03b1-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization","volume":"149","author":"Danaher","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2020.101109_bib179","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1","volume":"773","author":"Nilsson","year":"2016","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.molmet.2020.101109_bib180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12031-018-1202-3","article-title":"An intraperitoneal treatment with calcitonin gene-related peptide (CGRP) regulates appetite, energy intake\/expenditure, and metabolism","volume":"67","author":"Sanford","year":"2019","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.molmet.2020.101109_bib181","first-page":"E1","article-title":"Multiple metabolic effects of CGRP in conscious rats: role of glycogen synthase and phosphorylase","volume":"264","author":"Rossetti","year":"1993","journal-title":"American Journal Physiology Metablism"},{"key":"10.1016\/j.molmet.2020.101109_bib182","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/head.13379","article-title":"History and review of anti-calcitonin gene-related peptide (CGRP) therapies: from translational research to treatment","volume":"58","author":"Tepper","year":"2018","journal-title":"Headache: The Journal of Head and Face Pain"},{"key":"10.1016\/j.molmet.2020.101109_bib183","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","article-title":"Blocking CGRP in migraine patients \u2013 a review of pros and cons","volume":"18","author":"Deen","year":"2017","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.molmet.2020.101109_bib184","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2174\/1381612826666200318151146","article-title":"The importance of understanding amylin signaling mechanisms for therapeutic development in the treatment of Alzheimer's disease","volume":"26","author":"Servizi","year":"2020","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.molmet.2020.101109_bib185","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2337\/db16-1444","article-title":"Metabolic syndrome, insulin resistance, and cognitive Dysfunction: does your metabolic profile Affect your brain?","volume":"66","author":"Neergaard","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2020.101109_bib186","article-title":"Diet approach before and after bariatric surgery","author":"Bettini","year":"2020","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"10.1016\/j.molmet.2020.101109_bib187","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery","volume":"292","author":"Buchwald","year":"2004","journal-title":"Journal of the American Medical Association"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877820301836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877820301836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:25:53Z","timestamp":1761956753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877820301836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":184,"alternative-id":["S2212877820301836"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2020.101109","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2020.101109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101109"}}